13F filer · CIK 2100119 ↗
Vanguard Capital Management
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$3.67T
+8.0% on the quarter before
Positions
4,526
96 new · 174 sold out
Top 10
18.2%
of the value
Est. gain
+$240.81B
on stocks held all quarter
Est. return
+7.1%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Vanguard Capital Management's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Prologis~$2.72BAdded · 0.3% → 0.4%+24,130,362 shares
- Ferguson Plc New~$2.37BAdded · 0.0% → 0.1%+18,647,616 shares
- Microsoft~$2.02BAdded · 4.3% → 4.2%+8,426,183 shares
- Atlassian Corporation~$1.74BNew · 0.0% → 0.0%+13,536,164 shares
- Brookfield Corp~$1.55BNew · 0.0% → 0.0%+49,385,494 shares
- Amazon~$883.6MAdded · 2.3% → 1.6%+10,519,192 shares
- Broadcom~$786.7MAdded · 0.5% → 0.6%+1,406,972 shares
- Apple~$762.9MAdded · 5.2% → 4.5%+5,871,637 shares
- Tesla~$595.3MAdded · 1.7% → 0.7%+4,832,884 shares
- Unitedhealth Group Inc~$573.9MAdded · 1.2% → 1.2%+1,082,511 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Twitter Inc~$3.16BSold out · 0.1% → 0.0%−72,042,654 shares
- Duke Realty Corp~$2.44BSold out · 0.1% → 0.0%−50,723,773 shares
- Brookfield Asset Mgmt Inc~$1.90BSold out · 0.1% → 0.0%−46,380,575 shares
- Citrix Sys Inc~$1.51BSold out · 0.0% → 0.0%−14,540,446 shares
- Abiomed Inc~$1.29BSold out · 0.0% → 0.0%−5,269,340 shares
- Alleghany Corp Md~$1.03BSold out · 0.0% → 0.0%−1,225,743 shares
- Nielsen Hldgs Plc~$952.8MSold out · 0.0% → 0.0%−34,372,843 shares
- Zendesk Inc~$883.2MSold out · 0.0% → 0.0%−11,605,257 shares
- Mckesson Corp~$872.7MCut · 0.2% → 0.1%−2,326,444 shares
- Avalara Inc~$744.5MSold out · 0.0% → 0.0%−8,110,500 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.5% · price −6.0% | 4.5% | $166.08B | −$10.52B | ||||||||
| MicrosoftCOM · shares +1.3% · price +3.0% | 4.2% | $154.12B | +$4.39B | ||||||||
| AmazonCOM · shares +1.5% · price −25.7% | 1.6% | $59.81B | −$20.34B | ||||||||
| Unitedhealth Group IncCOM · shares +1.3% · price +5.0% | 1.2% | $44.56B | +$2.09B | ||||||||
| Johnson & JohnsonCOM · shares +0.6% · price +8.1% | 1.2% | $43.60B | +$3.26B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +0.9% · price +15.7% | 1.2% | $42.70B | +$5.74B | ||||||||
| AlphabetCAP STK CL A · shares +1.1% · price −7.8% | 1.2% | $42.55B | −$3.54B | ||||||||
| Exxon Mobil CorpCOM · shares −0.02% · price +26.3% | 1.1% | $40.66B | +$8.48B | ||||||||
| AlphabetCAP STK CL C · shares +0.1% · price −7.7% | 1.0% | $37.50B | −$3.13B | ||||||||
| Jpmorgan Chase & CoCOM · shares +0.8% · price +28.3% | 1.0% | $36.83B | +$8.07B | ||||||||
| Procter And Gamble CoCOM · shares +0.5% · price +20.0% | 0.93% | $34.21B | +$5.68B | ||||||||
| Visa Inc.COM CL A · shares +1.5% · price +16.9% | 0.83% | $30.61B | +$4.37B | ||||||||
| Home Depot IncCOM · shares +0.9% · price +14.5% | 0.82% | $30.11B | +$3.77B | ||||||||
| NvidiaCOM · shares +0.4% · price +20.4% | 0.81% | $29.90B | +$5.04B | ||||||||
| Chevron Corp NewCOM · shares −0.2% · price +24.9% | 0.78% | $28.55B | +$5.70B | ||||||||
| MastercardCL A · shares +1.3% · price +22.3% | 0.74% | $27.21B | +$4.90B | ||||||||
| Eli LillyCOM · shares +1.2% · price +13.1% | 0.73% | $26.86B | +$3.08B | ||||||||
| TeslaCOM · shares +2.3% · price −53.6% | 0.73% | $26.84B | −$30.26B | ||||||||
| Pfizer IncCOM · shares +1.6% · price +17.1% | 0.70% | $25.70B | +$3.69B | ||||||||
| Abbvie IncCOM · shares +1.5% · price +20.4% | 0.70% | $25.59B | +$4.28B | ||||||||
| Merck & Co IncCOM · shares +1.4% · price +28.8% | 0.69% | $25.21B | +$5.57B | ||||||||
| Pepsico IncCOM · shares +1.3% · price +10.7% | 0.64% | $23.58B | +$2.24B | ||||||||
| Coca Cola CoCOM · shares +1.4% · price +13.5% | 0.64% | $23.42B | +$2.76B | ||||||||
| BroadcomCOM · shares +3.7% · price +25.9% | 0.59% | $21.83B | +$4.33B | ||||||||
| MetaCL A · shares −0.4% · price −11.3% | 0.59% | $21.75B | −$2.77B | ||||||||
| Total · 4,526 positions | 100% | $3.67T | +$240.81B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 4,430 stocks held throughout, up $240.81B (+7.1%).
- Exxon Mobil Corp+$8.48B+26%
- Jpmorgan Chase & Co+$8.07B+28%
- Berkshire Hathaway Inc Del+$5.74B+16%
- Chevron Corp New+$5.70B+25%
- Procter And Gamble Co+$5.68B+20%
- Alphabet−$3.13B−8%
- Alphabet−$3.54B−8%
- Apple−$10.52B−6%
- Amazon−$20.34B−26%
- Tesla−$30.26B−54%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $4.68T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 (amended) | $4.00T−42% | SEC ↗ |
| Q4 2025 | Jan 29, 2026 | $6.90T+3% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 | $6.68T+8% | SEC ↗ |
| Q2 2025 | Aug 11, 2025 | $6.18T+12% | SEC ↗ |
| Q1 2025 | May 9, 2025 | $5.53T−4% | SEC ↗ |
| Q4 2024 | Feb 11, 2025 | $5.74T+3% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $5.58T+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $5.21T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $5.05T+10% | SEC ↗ |
| Q4 2023 | Mar 11, 2024 (amended) | $4.58T+12% | SEC ↗ |
| Q3 2023 | Dec 18, 2023 (amended) | $4.07T−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $4.22T+7% | SEC ↗ |
| Q1 2023 | Jul 14, 2023 (amended) | $3.93T+7% | SEC ↗ |
| Q4 2022 | Feb 10, 2023 | $3.67T+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $3.40T−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $3.56T−16% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $4.23T−4% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $4.40T+9% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $4.03T+0% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $4.02T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $3.70T+7% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $3.45T+14% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.02T+7% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.82T+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.35T−20% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $2.93T+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.70T+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $2.66T+4% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $2.55T+15% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $2.23T−13% | SEC ↗ |
| Q3 2018 | Dec 13, 2018 (amended) | $2.56T+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.39T+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $2.29T−0% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $2.29T+7% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.14T+5% | SEC ↗ |
| Q2 2017 | Aug 24, 2017 (amended) | $2.03T+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $1.95T+9% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.79T+5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.70T+6% | SEC ↗ |
| Q2 2016 | Aug 10, 2016 | $1.61T+4% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $1.54T | SEC ↗ |